Showing results (131-140 of 234) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphomaYasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.
The Lancet. Oncology|July 22, 2014
Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b studyAnas Younes, Catherine Thieblemont, Franck Morschhauser, et al.
Blood|December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignanciesIan W Flinn, Susan O'Brien, Brad Kahl, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
British Journal of Haematology|July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJason R Westin, Peter McLaughlin, Jorge Romaguera, et al.
Cancer Science|July 24, 2012
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in JapanYasuhiro Oki, Yutaka Kondo, Kazuhito Yamamoto, et al.
Genome Research|August 19, 2010
Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancerMarcos R H Estécio, Juan Gallegos, Céline Vallot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoidesYi An, Wen Jiang, Therese Y Andraos, et al.
Cancers|August 23, 2020
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell LymphomaAuris Huen, Bradley M Haverkos, Jasmine Zain, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2022
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical TrialsJesse G Dixon, Çağlar Çağlayan, Dai Chihara, et al.
Pageof 24